Article metrics

Download PDFPDF

33 Blood-based tumor mutation burden (bTMB) predicts response to immune checkpoint blockade-based combination therapy (ICBC) in advanced non-small cell lung cancer (NSCLC): a real-world (RW) analysis

 

Online download statistics by month:

Online download statistics by month: November 2023 to January 2024

AbstractFullPdf
Nov 2023184010
Dec 20235708
Jan 20241601
Total257019